News
Colgate-Palmolive Company (NYSE:CL) is one of the most profitable consumer stocks to buy now. UBS lowered its price target on ...
Colgate-Palmolive's growth is lackluster, with long-term sales and earnings barely keeping pace with inflation. Learn why CL ...
Santo Domingo.- Health authorities in the Dominican Republic have issued a warning about potential adverse reactions linked ...
StockStory.org on MSN17d
Colgate-Palmolive (CL): Buy, Sell, or Hold Post Q1 Earnings?Colgate-Palmolive trades at $92.78 per share and has stayed right on track with the overall market, gaining 6% over the last six months. At the same time, the S&P 500 has returned 5%. Is now a good ...
Colgate-Palmolive boasts strong brands, growth in Pet Nutrition, and 62 years of dividend increases but faces valuation concerns. See more on CL stock here.
Colgate-Palmolive's forward PE ratio is 22.48 compared to Procter & Gamble's 18.84 and Unilever's 19.30, indicating that Colgate-Palmolive is over-priced relative to its peers.
Colgate-Palmolive’s (NYSE: CL) stock has gone from $67.42 in November 2016 to $66.52 in November 2019. Over this period there has been a ~3% rise in total revenue and an equal drop in number of ...
Colgate-Palmolive’s chief executive recently signaled he would be open to selling the company — which has grappled with sluggish demand for its toothpaste, deodorants and food products — for ...
Colgate-Palmolive (CL 1.96%) has been a consumer stalwart for decades, reliably supplying customers with the toothpaste, dishwashing soap, and other household products they need.
Colgate-Palmolive announces its 2025 Sustainability & Social Impact Strategy, defining key actions & setting measurable targets for 2025 & beyond.
[Photo: Colgate] The company plans to roll out the tubes first in its U.S. sales of its Toms of Maine brand, followed by some global markets. By 2025, it plans to use the tubes in all of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results